Publication | Closed Access
537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers
31
Citations
0
References
2020
Year
EngineeringAdvanced CancersMedicinePathologyCancer BiologyCancer GeneticsSystems BiologyOncologyRadiation OncologyMolecular DiagnosticsFirst-in-human StudyCancer Research
No additional data available for this publication yet. Check back later!